About 15–20% of breast cancers do not express estrogen (ER) or progesterone receptors (PgR) (≤ 1%) or show human epidermal growth factor receptor 2 (HER 2) overexpression or amplification (Sporikova et al. 2018). This evidence concerns the gene PGR and breast cancer.